Hers GLP-1 Weight Loss Guide 2026: Injectable and Oral Treatment Options for Women (Semaglutide and Tirzepatide)

LOS ANGELES, January 16, 2026 (Newswire.com) - This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before starting any prescription treatment. A commission may be earned through links in this article at no additional cost to you.

Advertorial Disclosure: This is advertising content. Affiliate links are included; see full disclosure at the end of this article.

Hers GLP-1 Weight Loss for Women (2026): Program Overview, Medication Options, Pricing, and Safety

In Brief:Weight Loss by Hers offers a telehealth pathway where a licensed clinician may prescribe GLP-1 or other weight-management medications based on individual eligibility. The program includes both injectable and oral treatment options for women who qualify.

What This Guide Covers:

• Injectable GLP-1 options vs oral medication kits

• Semaglutide vs tirzepatide explained

• Compounded vs FDA-approved products

• Eligibility, pricing, safety, and regulatory context

Program availability varies by state and is not available in all 50 states. Verify availability in your area on the official Hers website: https://www.forhers.com/weight-loss

To view current Weight Loss by Hers program options, review eligibility and pricing details here. Program options, medication availability, and pricing can vary by state and eligibility. Confirm details on the official page.

What Is Weight Loss by Hers?

If you have been researching GLP-1 medications, you have probably noticed how complicated this space has become. Between insurance denials, month-long waits for specialist appointments, and confusing information about compounded versus branded drugs, it is easy to feel overwhelmed before you even start.

Weight Loss by Hers is a telehealth program operated by Hims & Hers Health, Inc. (NYSE: HIMS), a publicly traded company headquartered in San Francisco, California. The platform connects women with licensed healthcare providers who evaluate whether prescription weight loss medications may be appropriate based on individual health profiles.

Here is what that actually means in plain terms: instead of booking an appointment weeks out with a weight management specialist, you complete an online health assessment, a licensed clinician reviews your information, and if they determine you are a candidate, medication can be prescribed and shipped to you.

That said, it is not a guarantee. Not everyone who applies will receive a prescription. That determination rests entirely with the evaluating clinician based on your specific health situation. For people using a cash-pay approach, it can reduce the need to navigate insurance prior authorization.

Understanding the Three-Entity Structure

This matters more than most people realize, so here is the breakdown.

Hers (the platform) provides the technology, customer service, and coordination. Think of it as the infrastructure that connects everything. According to the company's published terms, Hers itself is not a healthcare provider. It is the technology that facilitates the experience.

Licensed medical providers review your information and make prescribing decisions. These clinicians evaluate your complete health picture and determine whether medication may be appropriate for your situation.

Partner pharmacies fill the prescriptions. For compounded medications, these are licensed compounding pharmacies. For branded medications, prescriptions go through licensed retail or specialty pharmacies.

Why does this structure matter to you? Because it means the person deciding whether you receive medication is a clinician making an individualized medical decision based on the information provided.

Brand and Trademark Note: Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. All trademarks are property of their respective owners. Hims & Hers Health, Inc. is not affiliated with or endorsed by these companies.

How the Hers GLP-1 Weight Loss Program Works

Here is what actually happens if you decide to explore this.

Step 1: You Answer Questions Online. The intake covers your medical history, current medications, lifestyle, and what you are hoping to achieve. Be thorough here. The clinician can only work with the information you provide.

Step 2: A Licensed Clinician Reviews Your Answers. This is not an algorithm auto-approving everyone. A licensed healthcare provider trained in weight management looks at your complete picture and determines whether medication might be appropriate for your situation. Some people get prescribed medication; some do not. That is how it should work.

Step 3: If Prescribed, Medication Ships to You. According to the company, your treatment arrives with necessary supplies included. Shipping timelines vary depending on the medication type and your location.

Step 4: Ongoing Communication. You can message providers through the platform for questions, to report how things are going, or to request adjustments. For many people, online messaging can be a convenient way to ask follow-up questions, though response times may vary.

To see how the process works in detail, view current program options here. You can also visit the official page at https://www.forhers.com/weight-loss for complete information.

Injectable GLP-1 Options

When people talk about GLP-1 weight loss medications, they are usually talking about injectables. These are the weekly shots that have been making headlines for the past few years.

What Injectable Actually Looks Like

If you are prescribed an injectable, you will self-administer it subcutaneously (just under the skin), typically once per week. Patients are instructed on administration technique if prescribed an injectable. Branded medications come in pre-filled pens designed for easy self-injection. Compounded medications typically come in vials with separate syringes.

Compounded Injectable GLP-1s

Hers may offer access to compounded GLP-1 prescriptions in some cases, depending on clinician determination, state availability, and current program offerings. Always confirm current offerings on the official page at https://www.forhers.com/weight-loss.

Here is what you need to understand: compounded medications are not FDA-approved as finished products. The FDA does not evaluate compounded drugs for safety, effectiveness, or quality before they are dispensed. Compounded products may use semaglutide as an ingredient, but they are not the same as FDA-approved medications like Wegovy or Ozempic.

That does not mean compounded medications are necessarily unsafe. Compounding is a legitimate, regulated pharmaceutical practice. But it does mean they have not gone through the same approval process as branded drugs.

Branded Injectable GLP-1s

Hers also offers access to FDA-approved branded medications, which have undergone full FDA review.

Wegovy (semaglutide) is FDA-approved specifically for chronic weight management in adults meeting certain criteria.

Zepbound (tirzepatide) is FDA-approved specifically for chronic weight management in adults meeting certain criteria.

Ozempic (semaglutide) and Mounjaro (tirzepatide) are FDA-approved for type 2 diabetes management but may be prescribed off-label for weight management at a clinician's discretion.

Branded medications cost significantly more than compounded options. Availability may vary based on supply and your specific situation.

Oral Weight Loss Options

Not everyone wants to give themselves weekly injections, and that is completely reasonable. Hers offers oral medication kits as an alternative for women who prefer pills or who may not be candidates for GLP-1 injectables.

What Is Actually in the Oral Kits

The specific combination depends on what your prescribing clinician determines is appropriate for you, but kits may include the following:

Bupropion was originally developed as an antidepressant and is sometimes prescribed off-label in combination with other medications to support weight management by affecting appetite and reward pathways.

Metformin is FDA-approved for type 2 diabetes and is sometimes prescribed off-label as part of weight management approaches.

Topiramate is an anticonvulsant with appetite-affecting properties, sometimes included in weight loss medication combinations.

Naltrexone affects appetite signaling when combined with other medications.

Vitamin B12 is sometimes included to support energy levels.

One important note: oral medication kits are compounded products. They are not FDA-approved as finished drugs. The FDA does not evaluate compounded drugs for safety, effectiveness, or quality before they are dispensed.

Who Might Consider Oral Options

Oral kits might make sense for women who are not comfortable with self-injection, who may not meet eligibility criteria for GLP-1 medications, who want a lower-cost starting point, or whose clinician determines oral medications are more appropriate based on their health history.

Hers GLP-1 Weight Loss vs Oral Kits: How Women Choose With a Clinician

This is one of the most common questions: Should I try GLP-1 injectables or start with oral medication kits?

The honest answer is that it depends on your situation, and ultimately your clinician helps guide that decision. Here is what typically factors in.

GLP-1 injectables may be considered when you meet BMI criteria (typically 30 or higher, or 27 or higher with weight-related health conditions), you are comfortable with weekly self-injection, and your health profile does not include contraindications for GLP-1 medications.

Oral kits may be considered when you prefer not to inject, you do not meet GLP-1 eligibility criteria, cost is a significant factor, or your clinician determines the oral combination is better suited to your health profile.

What this is not: a self-selection menu where you pick whichever sounds better. The clinician evaluates your complete health picture and recommends what may be appropriate. Sometimes that is different from what you initially wanted, and that is actually a sign the process is working as it should.

Semaglutide vs Tirzepatide

These names come up constantly in weight loss discussions. Here is what they actually mean.

Semaglutide: The Basics

Semaglutide is a pharmaceutical ingredient, specifically a GLP-1 receptor agonist. It is the active ingredient in Ozempic (FDA-approved for type 2 diabetes), Wegovy (FDA-approved for weight management), and Rybelsus (oral form, FDA-approved for type 2 diabetes).

When you hear about compounded semaglutide, it means a compounded medication that may use semaglutide as an ingredient. But compounded products are not the same as these FDA-approved medications.

Tirzepatide: The Basics

Tirzepatide works on two hormone pathways instead of one (GLP-1 and GIP, making it a dual agonist). It is the active ingredient in Mounjaro (FDA-approved for type 2 diabetes) and Zepbound (FDA-approved for weight management).

Which One Is Better?

Clinical trials have shown both can be effective for weight management. Some studies suggest tirzepatide may produce somewhat greater weight loss in some populations, but direct head-to-head comparisons are limited, and "better" depends entirely on individual factors.

The choice, when both are options, depends on your health profile, how you respond to medication, cost considerations, and your clinician's judgment.

The key point: the ingredient is not the same as the finished drug. FDA approval applies to specific finished products manufactured under controlled conditions, not to the ingredient in general.

Compounded vs FDA-Approved GLP-1s

This distinction confuses almost everyone. Here is what you need to know.

FDA-Approved Medications

Wegovy, Zepbound, Ozempic, and Mounjaro are specific finished products that have undergone extensive FDA review. The FDA has evaluated these exact products for safety, effectiveness, and manufacturing quality. They are made by pharmaceutical manufacturers under strict oversight.

Compounded Medications

Compounded medications are prepared by licensed pharmacies, often to create customized doses or formulations. Compounding is a legitimate, regulated pharmaceutical practice that has existed for a long time.

However, and this is important, compounded medications are not FDA-approved as finished products. The FDA does not evaluate compounded drugs for safety, effectiveness, or quality before they are dispensed.

What This Means Practically

When Hers or any telehealth platform offers compounded GLP-1 options, these are not Ozempic, Wegovy, Mounjaro, or Zepbound. Some compounded prescriptions may use certain GLP-1-related ingredients. Availability and offerings vary by state and by program. Always confirm current options on the official page.

This does not automatically mean compounded medications are dangerous. It means you should understand what you are receiving and make an informed decision.

What GLP-1 Actually Means

If you are going to consider these medications, it helps to understand what they actually do in plain terms rather than pharmaceutical jargon.

The Natural Version

GLP-1 stands for glucagon-like peptide-1. Your body already makes this hormone naturally. After you eat, your intestines release GLP-1, which does three main things: it signals your brain that you have eaten, it helps regulate blood sugar by triggering insulin release, and it slows down how fast food leaves your stomach.

The Medication Version

GLP-1 medications are synthetic versions of this hormone that work at higher levels than your body typically produces. The result can include reduced appetite and what many people describe as quieter "food noise" (that constant background thinking about food), longer-lasting fullness after eating, and better blood sugar regulation.

What This Does Not Mean

GLP-1 medications are not magic. They work alongside dietary changes and physical activity, not instead of them. They are tools that may make the work of weight management more achievable for some people, but they are still tools, not solutions that work passively.

What Off-Label Prescribing Means

You will see "off-label" mentioned throughout this guide. Some people hear that term and worry. Here is what it actually means.

The Definition

Off-label prescribing means a licensed clinician prescribes a medication for a use other than its specific FDA-approved indication. The medication itself is FDA-approved, just not for that particular purpose.

Examples You Will Encounter

Ozempic is FDA-approved for type 2 diabetes but may be prescribed off-label for weight management. Mounjaro is FDA-approved for type 2 diabetes but may be prescribed off-label for weight management. Metformin is FDA-approved for type 2 diabetes but may be prescribed off-label as part of weight management approaches.

Is Off-Label Prescribing Safe?

Off-label prescribing is legal, common, and based on clinician judgment and available evidence. It happens across medicine, not just in weight management. That said, off-label use may be appropriate for some patients, but it is not right for everyone and should be evaluated by a clinician based on your individual situation.

Hers Weight Loss Eligibility Checklist (What Clinicians Typically Look For)

Not everyone who applies to Weight Loss by Hers will receive a prescription. Here is what typically factors into eligibility, though final determination always rests with the evaluating clinician.

General BMI Considerations

GLP-1 medications are generally indicated for adults with obesity (BMI of 30 or higher) or adults with overweight (BMI of 27 or higher) who also have at least one weight-related health condition.

However, these are general guidelines, not automatic qualifiers. The clinician looks at your complete picture.

Factors That May Affect Eligibility

Certain conditions may preclude eligibility for specific medications. These can include personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, history of pancreatitis, certain kidney or gallbladder conditions, pregnancy or breastfeeding, and other individual health factors.

Your current medications also matter. Some drug interactions may affect what can be prescribed.

State Availability

This catches some people off guard: program availability varies by state and is not available in all 50 states. Verify availability in your area before starting the intake process at https://www.forhers.com/weight-loss.

What Eligibility Evaluation Is Not

It is not a rubber stamp. It is not guaranteed approval if you meet BMI criteria. It is a medical professional evaluating whether a specific treatment is appropriate for your specific situation.

Hers GLP-1 Weight Loss Pricing: What Affects Cost

Pricing for Weight Loss by Hers depends on several factors. Understanding what drives cost can help you evaluate whether this approach fits your budget.

State Availability. Not all options are available in all states, which can affect what you are offered and at what price point.

Plan Length. Longer subscription commitments (such as 6-month or 10-month plans paid upfront) typically result in lower monthly rates. Shorter plans cost more per month.

Branded vs Compounded (If Offered). FDA-approved branded medications like Wegovy and Zepbound cost significantly more than compounded alternatives. The specific options available to you depend on clinician determination and current program offerings.

Clinician Eligibility Determination. You do not pick from a menu. The clinician determines what may be appropriate for your situation, which affects what you are offered.

Supply and Program Changes. Medication availability and pricing can change based on supply, regulatory developments, and program updates. Always verify current pricing on the official page before making decisions.

Pricing, Plans, and Payment Structure

Here is what this actually costs, with the understanding that pricing can change and you should always verify current information before making decisions.

Published Pricing (Subject to Change)

According to publicly available information from the company:

Oral medication kits start at approximately $69 per month with a 10-month plan paid upfront in full. Shorter subscription terms are available at higher monthly rates.

Compounded GLP-1 injectables start at approximately $199 per month with a 6-month plan paid upfront in full. Shorter options (2-month, 4-month) are available at higher monthly rates.

Branded GLP-1 medications are priced significantly higher than compounded options. Actual price depends on the product and plan selected and may change.

Pricing and included services can change; confirm current totals and terms on the official page before purchasing.

The Payment Model

Hers does not require insurance. Plans typically require upfront payment for the selected subscription term, meaning you are paying for multiple months at once to lock in the lower monthly rate.

According to the company, treatments may be eligible for HSA or FSA reimbursement, though eligibility varies by plan. Verify with your plan administrator.

Important: Review cancellation and refund policies directly on the Hers website before committing. Understand what happens if you need to stop treatment early.

All pricing is subject to change. Always verify current pricing at https://www.forhers.com/weight-loss before making decisions.

To review current pricing and eligibility details, view program options here.

Safety and Side Effects

Any prescription medication comes with potential side effects. This overview is not exhaustive. Always discuss risks thoroughly with your healthcare provider.

Common GLP-1 Side Effects

According to clinical literature and FDA labeling for approved GLP-1 medications, commonly reported side effects include nausea (especially when starting or after dose increases), vomiting, diarrhea, constipation, abdominal discomfort, decreased appetite, fatigue, and injection site reactions (for injectables).

Many users report that gastrointestinal side effects are most pronounced when starting and tend to diminish over time. But "tend to" is not a guarantee. Some people discontinue treatment because side effects remain intolerable for them.

Oral Medication Kit Considerations

The medications in oral kits have their own profiles. Bupropion carries an FDA black box warning regarding suicidal thoughts in certain populations and is contraindicated for people with seizure disorders or eating disorders. Metformin may cause gastrointestinal effects. Topiramate may cause cognitive effects or tingling sensations.

When to Get Help

Seek medical attention for severe or persistent symptoms or any concerning reactions. Do not try to tough it out if something feels wrong.

This overview is not comprehensive. Always review complete prescribing information and discuss potential risks with your healthcare provider before starting any treatment.

Regulatory and FDA Considerations

The regulatory landscape for GLP-1 weight loss medications has been evolving. Here is what you should know.

Compounded GLP-1 Regulatory Status

Compounded medications exist in a different regulatory category than FDA-approved drugs. While compounding pharmacies are regulated at state and federal levels, compounded finished products do not undergo FDA approval for safety, effectiveness, or quality.

The FDA issued a Warning Letter to Hims & Hers Health, Inc. dba Hers dated September 9, 2025, regarding certain compounded semaglutide marketing claims. This reflects broader regulatory attention to how compounded GLP-1 products are marketed across the telehealth industry.

Shortage Status Changes

The FDA declared the semaglutide shortage resolved in February 2025. This affects the regulatory framework under which compounded semaglutide products may be prepared and distributed. The landscape continues to evolve.

Regulatory Snapshot (U.S.)

Several regulatory bodies have oversight relevant to telehealth weight loss programs:

FDA and FDCA provide oversight of drug marketing, misbranding, and compounding frameworks. Compounded drugs are not FDA-approved finished products.

State Medical Boards govern clinician licensure and standard-of-care requirements for telehealth prescribing.

State Boards of Pharmacy handle pharmacy licensure, dispensing standards, and compounding oversight (with federal overlays for 503A and 503B facilities).

FTC enforces advertising and endorsement rules, including affiliate disclosure expectations.

HIPAA and State Privacy Laws govern health data handling. Do not assume any platform is HIPAA-compliant unless explicitly stated in their published policies.

What This Means for You

Regulatory complexity does not mean compounded medications are necessarily unsafe or that telehealth platforms are illegitimate. It means you should understand what you are receiving, ask questions, and verify current information directly with providers.

What Hers Does NOT Guarantee

Being clear about limitations builds trust. Here is what Hers cannot promise.

No guaranteed prescription. Completing the intake does not mean you will receive medication. Clinicians make independent determinations based on individual eligibility.

No guaranteed results. Weight management outcomes vary significantly based on individual factors, adherence, lifestyle, genetics, and other variables. Self-reported customer outcomes are not independently verified and should not be interpreted as typical or guaranteed.

Not available in all states. Program availability varies by state.

Compounded products are not FDA-approved as finished drugs. If you receive a compounded medication, it has not undergone FDA review as a finished product.

Response times may vary. While Hers offers online provider messaging, response times are not guaranteed.

Who This May Be For

Weight Loss by Hers may align with women who prefer online healthcare access and find telehealth more practical than scheduling in-person appointments, who are comfortable with the cash-pay model and do not want to navigate insurance pre-authorization hurdles, who want to explore whether GLP-1 or oral weight loss medications might be appropriate for their situation, who appreciate having both injectable and oral options available depending on what a clinician recommends, and who value digital support tools and the flexibility of managing their care through an app.

Who Should Consider Other Options

This program is not the right fit for everyone. Other pathways may work better for women who have complex medical histories that would benefit from in-person, hands-on evaluation rather than telehealth assessment, who value face-to-face relationships with their healthcare providers and prefer that dynamic, who have insurance that covers GLP-1 medications and want to maximize that coverage rather than paying out of pocket, who are only comfortable with FDA-approved branded medications and do not want to consider compounded options, or who prefer not to commit to upfront multi-month payments.

If any of these describe you, working with an in-person physician, endocrinologist, or weight management specialist might be a better path.

Hers GLP-1 Weight Loss: Common Questions Women Ask Before Starting

Before committing to any weight loss program, most women have similar concerns. Here are the questions that come up most often.

Will I definitely get a prescription? No. Completing the intake does not guarantee you will receive medication. A licensed clinician evaluates your health profile and makes an independent determination about whether medication is appropriate for your situation.

What if I cannot tolerate the side effects? Side effects vary by person. Many users report that initial gastrointestinal effects diminish over time, but this is not universal. You can communicate with providers through the platform about adjusting your approach if needed.

Is this actually cheaper than going through my doctor? It depends on your insurance situation. If your insurance covers GLP-1 medications with reasonable copays, that may be more cost-effective. If you are facing denials, high copays, or no coverage, the cash-pay model may work better for you.

How do I know if compounded medication is right for me? This is a conversation to have with the prescribing clinician. Some women prefer FDA-approved branded medications. Others are comfortable with compounded options at lower price points. Understanding the regulatory distinction (covered earlier in this guide) helps you ask informed questions.

What happens if I want to stop? Review the specific cancellation and refund policies for your plan before subscribing. Policies vary by subscription type and length.

Should I tell my regular doctor? Yes. Even if you are accessing medication through a telehealth platform, your primary care provider should know about any medications you are taking. This ensures coordinated care and helps avoid potential interactions.

Frequently Asked Questions

Is Hers a legitimate company?

Hers is operated by Hims & Hers Health, Inc., a publicly traded company on the New York Stock Exchange (NYSE: HIMS) headquartered in San Francisco, California. The company operates across multiple telehealth categories.

Is Hers GLP-1 weight loss available in my state?

Program availability varies by state and is not available in all 50 states. Verify availability at https://www.forhers.com/weight-loss before beginning the intake process.

Does Hers offer semaglutide or tirzepatide options?

Program offerings may include clinician-prescribed options associated with semaglutide or tirzepatide, depending on eligibility, state availability, and current program details. Always confirm current options on the official page.

What is the difference between compounded semaglutide and Wegovy?

Wegovy is an FDA-approved finished product manufactured by Novo Nordisk that has undergone FDA review for safety, effectiveness, and quality. Compounded medications may use semaglutide as an ingredient but are not FDA-approved as finished products. The FDA does not evaluate compounded drugs for safety, effectiveness, or quality before they are dispensed. They are different products with different regulatory status.

How does the online intake work?

You complete a health questionnaire online covering your medical history, medications, lifestyle, and goals. A licensed healthcare provider reviews your information and determines whether medication may be appropriate. If prescribed, medication ships to you. The intake does not guarantee you will receive a prescription.

Does Hers require insurance?

According to the company, Hers does not require insurance for weight loss treatments. HSA and FSA reimbursement eligibility varies by plan. Verify with your plan administrator.

What if I experience side effects?

Hers offers online messaging for provider communication. Response times may vary. For severe or persistent symptoms or any concerning reactions, seek immediate medical attention.

Can I cancel my subscription?

Review cancellation and refund policies directly on the Hers website before subscribing. Policies may vary by plan type and subscription length.

Is Weight Loss by Hers a telehealth service or a pharmacy?

Hers is a telehealth platform, not a pharmacy. The platform connects you with licensed healthcare providers who evaluate your health information and make prescribing decisions. If a prescription is written, it is filled by a separate licensed pharmacy (either a compounding pharmacy or a retail or specialty pharmacy depending on the medication).

What questions should I ask the clinician before starting?

Consider asking about the difference between compounded and FDA-approved options, what side effects to expect and how to manage them, how long you should expect to be on medication, what happens if you need to stop treatment, and how the medication interacts with any other medications or supplements you take. The more informed you are, the better decisions you can make.

Summary

Weight Loss by Hers provides a telehealth pathway for women to explore prescription weight loss medications, including both injectable GLP-1 options (compounded and branded) and oral medication kits. The platform connects users with licensed providers who evaluate eligibility based on individual health profiles.

The key things to remember: compounded medications are not FDA-approved as finished products and should be understood as distinct from branded medications; not everyone who applies will receive a prescription; results vary and self-reported outcomes are not independently verified; program availability varies by state; and pricing requires upfront payment for multi-month subscription terms.

For women seeking telehealth convenience and cash-pay accessibility, Hers represents one option in a growing market. Whether it is the right option depends on your individual health circumstances, comfort with compounded versus FDA-approved medications, and personal preferences for how you receive healthcare.

For complete program details, visit the official Hers weight loss page at https://www.forhers.com/weight-loss or review current eligibility and pricing options here.

Support: https://support.hims.com/hc/en-us

Phone: 1-800-368-0038

Disclaimers

Content and Medical Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Weight loss medications require evaluation by a licensed clinician. The information provided does not replace the professional judgment of your healthcare provider.

Professional Medical Disclaimer: This article is educational and does not constitute medical advice. If you are currently taking medications, have existing health conditions, are pregnant or nursing, or are considering any major changes to your health regimen, consult your physician before starting any prescription treatment. Do not change, adjust, or discontinue any medications without your physician's guidance.

Compounded Medication Notice: Compounded medications are prepared by licensed pharmacies based on individual prescriptions. Compounded medications are not reviewed or approved by the FDA as finished products. The FDA does not evaluate compounded drugs for safety, effectiveness, or quality before they are dispensed.

Results Disclaimer: Individual results vary based on numerous factors including age, baseline health, adherence, lifestyle, genetics, and other variables. Any results referenced from company materials represent self-reported customer data, not clinical trial results, and are not independently verified. Self-reported outcomes should not be interpreted as typical or guaranteed.

FTC Affiliate Disclosure: This article contains affiliate links. If you access the program through these links, a commission may be earned at no additional cost to you. This compensation does not influence the accuracy or integrity of the information presented.

Pricing Disclaimer: All pricing information was accurate according to publicly available sources at the time of publication (January 2026) but is subject to change. Actual price depends on the product and plan selected. Plans typically require upfront payment. Always verify current pricing, terms, and refund policies at https://www.forhers.com/weight-loss before making decisions.

Availability Disclaimer: Program availability varies by state and is not available in all 50 states. Verify availability in your area before beginning the intake process.

Brand and Trademark Notice: Ozempic, Wegovy, Rybelsus, Saxenda, and Victoza are registered trademarks of Novo Nordisk A/S. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. All trademarks are property of their respective owners. Hims & Hers Health, Inc. is not affiliated with or endorsed by these trademark owners. No affiliation or endorsement is implied.

Publisher Responsibility: The publisher has made every effort to ensure accuracy based on publicly available information. We do not accept responsibility for errors, omissions, or outcomes resulting from the use of this information. Verify all details directly with Hers and your healthcare provider before making decisions.

Regulatory Context: The telehealth weight loss industry, particularly regarding compounded medications, is subject to evolving regulatory oversight. Verify current regulatory status and medication availability with your provider.

SOURCE: Hers

Source: Hers